Multiple Factors Influencing the Incidence of Congenital Hypothyroidism Detected by Neonatal Screening
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Background/Aims: Over the years a rise in the incidence of congenital hypothyroidism (CH) has been described worldwide. The aim of our study was to investigate trends in the incidence of CH in Italy over the period 1987-2008, and to investigate which factors may have influenced the CH incidence in our country. Methods: Data were derived from the Italian National Registry of Infants with Congenital Hypothyroidism. Since 1998 the laboratory procedures related to neonatal screening for CH have changed drastically. Accordingly, we estimated the CH incidence during the period 1987-1998 (period 1) and the period 1999-2008 (period 2). Results: The incidence of CH confirmed at birth (including transient hypothyroidism) has increased from 1:3,000 liveborn infants in period 1 to 1:1,940 in period 2 (+54%), whereas the incidence of purely permanent CH increased from 1:3,200 to 1:2,320 (+38%). Lowering of the TSH cutoff was the most important factor contributing to the increase of CH incidence in Italy. Moreover, an increment of 58% of preterm babies with permanent CH was found in period 2 compared with period 1. Conclusion: Our results suggest that more than one cause is responsible for the rise in the increasing CH incidence, with lowering of the screening TSH cutoff and an increased survival rate of a growing number of preterm babies both playing an important role.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This can be partly explained by the lowering of neonatal screening TSH cut-off values, resulting in the detection of newborns who would have been missed otherwise (false negatives) (8), but also in finding children with biochemically milder forms of CH (mostly with thyroid GIS) (9–11).”
In the citing paper
“In contrast, factors such as prematurity (11,142,143), other congenital abnormalities (141), a family history of thyroid disease (142), abnormal thyroid morphology (thyroid hypoplasia at diagnosis) (142), TSH elevation >10 mU/L after the age of 1 year (when infants outgrow the LT4 dose), and a higher LT4 dose requirement at 1 to 3 years of age are associated with permanent CH”
Citations
Cites
The Worldwide Incidence of Preterm Birth: A Systematic Review of Maternal Mortality and Morbidity
Beck, S., Wojdyla, D., Say, L., Pilar Bertran, A., Meraldi, M., Harris Requejo, J., Rubens, C., Menon, R., & Van Look, P. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.08.062554 · Cited by 1,523
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
Self-citationScreening for congenital hypothyroidism: Results of screening one million North American infants
Fisher, D. A., Dussault, J. H., Foley, T. P., Klein, A. H., LaFranchi, S., Larsen, P. R., Mitchell, M. L., Murphey, W. H., & Walfish, P. G. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80133-x · Cited by 372
RE, R. N., KOURIDES, I. A., RIDGWAY, E. C., WEINTRAUB, B. D., & MALOOF, F. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-43-2-338 · Cited by 301
Screening for congenital hypothyroidism: A worldwide view of strategies
Ford, G., & LaFranchi, S. H. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.008 · Cited by 274
Corbetta, C., Weber, G., Cortinovis, F., Calebiro, D., Passoni, A., Vigone, M. C., Beck‐Peccoz, P., Chiumello, G., & Persani, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03568.x · Cited by 247
Deladoëy, J., Ruel, J., Giguère, Y., & Van Vliet, G. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1073 · Cited by 235
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · Hormone Research in Paediatrics · doi:10.1159/000358198 · Cited by 208
Self-citationHinton, C. F., Harris, K. B., Borgfeld, L., Drummond-Borg, M., Eaton, R., Lorey, F., Therrell, B. L., Wallace, J., & Pass, K. A. (2010) · Pediatrics · doi:10.1542/peds.2009-1975d · Cited by 207
Developmental Trends in Cord and Postpartum Serum Thyroid Hormones in Preterm Infants
Williams, F. L. R., Simpson, J., Delahunty, C., Ogston, S. A., Bongers-Schokking, J. J., Murphy, N., van Toor, H., Wu, S.-Y., Visser, T. J., & Hume, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0869 · Cited by 188
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“In contrast, factors such as prematurity (11,142,143), other congenital abnormalities (141), a family history of thyroid disease (142), abnormal thyroid morphology (thyroid hypoplasia at diagnosis) (142), TSH elevation >10 mU/L after the age of 1 year (when infants outgrow the LT4 dose), and a higher LT4 dose requirem…”
BackgroundWassner, A. J. (2018) · Clinics in Perinatology · doi:10.1016/j.clp.2017.10.004 · Cited by 165
Congenital hypothyroidism: recent advances
Wassner, A. J., & Brown, R. S. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000181 · Cited by 120
Congenital Hypothyroidism: Screening and Management
Rose, S. R., Wassner, A. J., Wintergerst, K. A., Jones, N. Y., Hopkin, R. J., Chuang, J., Smith, J. R., Abell, K. B., LAFRANCHI, S. H., Wintergerst, K. A., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2022-060420 · Cited by 129
Congenital hypothyroidism: insights into pathogenesis and treatment
Cherella, C. E., & Wassner, A. J. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0051-0 · Cited by 106
“Whereas dyshormonogenesis accounted for only 15% of congenital hypothyroidism diagnosed in the early days of newborn screening, 30–40% of infants diagnosed by current newborn screening strategies have a eutopic thyroid gland consistent with a form of dyshormonogenesis [3, 5, 6].”
BackgroundAre lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted?
Lain, S., Trumpff, C., Grosse, S. D., Olivieri, A., & Van Vliet, G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0107 · Cited by 96
Self-citationPediatric Hypothyroidism: Diagnosis and Treatment
Wassner, A. J. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0238-0 · Cited by 116
“this pattern has shifted with recent changes in newborn screening strategies and demographics and, in several recent studies, 30–40% of infants diagnosed with congenital hypothyroidism had a eutopic thyroid gland consistent with a form of dyshormonogenesis [3, 4, 6].”
Congenital Hypothyroidism: Screening and Management
Rose, S. R., Wassner, A. J., Wintergerst, K. A., Jones, N. Y., Hopkin, R. J., Chuang, J., Smith, J. R., Abell, K. B., LAFRANCHI, S. H., Wintergerst, K. A., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2022-060419 · Cited by 132
Barry, Y., Bonaldi, C., Goulet, V., Coutant, R., Léger, J., Paty, A.-C., Delmas, D., Cheillan, D., & Roussey, M. (2016) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.11.005 · Cited by 86
Incidence of Congenital Hypothyroidism Over 37 Years in Ireland
McGrath, N., Hawkes, C. P., McDonnell, C. M., Cody, D., O'Connell, S. M., Mayne, P., & Murphy, N. (2018) · PEDIATRICS · doi:10.1542/peds.2018-1199 · Cited by 83
McGrath, N., Hawkes, C. P., Mayne, P., & Murphy, N. P. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.09.044 · Cited by 57
Messina, M. F., Aversa, T., Salzano, G., Zirilli, G., Sferlazzas, C., De Luca, F., & Lombardo, F. (2015) · Hormone Research in Paediatrics · doi:10.1159/000435811 · Cited by 55
Saba, C., Guilmin-Crepon, S., Zénaty, D., Martinerie, L., Paulsen, A., Simon, D., Storey, C., Dos Santos, S., Haignere, J., Mohamed, D., et al. (2018) · Thyroid · doi:10.1089/thy.2018.0154 · Cited by 51
“…been identified as potential modifiers, and other factors, such as a family history of thyroid disease in first-degree relatives, thyroid morphology at diagnosis, and sex, have been identi-fied as potentially useful elements for differentiating between permanent and transient forms of CH (2,6,9,11–20).”
Mild Hypothyroidism in Childhood: Who, When, and How Should Be Treated?
Vigone, M. C., Capalbo, D., Weber, G., & Salerno, M. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00471 · Cited by 51
Effects of Mild Perinatal Hypothyroidism on Cognitive Function of Adult Male Offspring
Amano, I., Takatsuru, Y., Khairinisa, M. A., Kokubo, M., Haijima, A., & Koibuchi, N. (2018) · Endocrinology · doi:10.1210/en.2017-03125 · Cited by 54
Deng, K., He, C., Zhu, J., Liang, J., Li, X., Xie, X., Yu, P., Li, N., Li, Q., & Wang, Y. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0361 · Cited by 50
Anne, R. P., & Rahiman, E. A. (2022) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2022.100040 · Cited by 50
Kang, M.-J., Chung, H.-R., Oh, Y.-J., Shim, Y.-S., Yang, S., & Hwang, I.-T. (2017) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2017.01.002 · Cited by 45
Wright, M. T., Kouba, L., & Plate, L. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002168 · Cited by 40
“but devising such strategies would be particularly critical considering the increased prevalence of dyshormonogenesis among newborns and complications arising from the current “gold standard” of hormone therapy treatments in the clinic (7, 21).”
BackgroundNeonatal Screening for Congenital Hypothyroidism: What Can We Learn From Discordant Twins?
Medda, E., Vigone, M. C., Cassio, A., Calaciura, F., Costa, P., Weber, G., de Filippis, T., Gelmini, G., Frenna, M. D., Caiulo, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00900 · Cited by 34
Self-citationCaiulo, S., Corbetta, C., Frenna, M. D., Medda, E., Angelis, S. D., Rotondi, D., Vincenzi, G., de Filippis, T., Patricelli, M. G., Persani, L., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa789 · Cited by 33
Self-citationJung, J. M., Jin, H. Y., & Chung, M. L. (2016) · Hormone Research in Paediatrics · doi:10.1159/000443399 · Cited by 28
Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020
Gaviglio, A., McKasson, S., Singh, S., & Ojodu, J. A. (2023) · International Journal of Neonatal Screening · doi:10.3390/ijns9020023 · Cited by 28
“The lack of long-term follow-up data on these newborns also limits the ability to determine how many CH cases represent permanent versus transient cases [13].”
BackgroundZhou, J., Luo, J., Lin, J., Zeng, Y., Qiu, X., Zhu, W., & Liu, G. (2020) · Medicine · doi:10.1097/md.0000000000020838 · Cited by 32
“Congenital hypothyroidism (CH) is one of the most common neonatal endocrine diseases, and with the increasing availability of neonatal screening programs, improved thyroid-stimulating hormone (TSH) assay sensitivity, and increased survival rate of preterm infants, the incidence of CH has increased worldwide.([1,2]) Ho…”
BackgroundIncidence of primary congenital hypothyroidism over 24 years in Finland
Danner, E., Niuro, L., Huopio, H., Niinikoski, H., Viikari, L. A., Kero, J. T., & Jääskeläinen, J. (2022) · Pediatric Research · doi:10.1038/s41390-022-02118-4 · Cited by 24
“Re-evaluation of the diagnosis, if needed, is performed at 2 or 3 years of age to detect transient CH. Imaging of the thyroid (scintigraphy) was routinely performed in the 1980s.”
BackgroundInfluentialYao, Y., Deng, K., Zhu, J., Xiang, L., Yuan, X., Qi Li, M. S. E., Liu, L., Guo, Y., 刘瀚旻, & Li, X. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05108-8 · Cited by 23
“Immaturity of the hypothalamic-pituitary-thyroid axis and an increase in thyroid hormone requirement mean that preterm neonates are more vulnerable to thyroid dysfunction than term neonates [31, 43].”
BackgroundWest, R., Hong, J., Derraik, J. G. B., Webster, D., Heather, N. L., & Hofman, P. L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa415 · Cited by 20
Özer, Y., Anık, A., Sayılı, U., Tercan, U., Sevim, R. D., Güneş, S., Pirimoğlu, M. B., Elmaoğulları, S., Dündar, İ., Ökdemir, D., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02348-9 · Cited by 20
“The increased incidence is explained by the strategy changes in NBS with the introduction of lower thresholds to increase sensitivity and increased preterm deliveries with increased survival rates of infants born preterm [2, 8–10].”
BackgroundYao, Y., Yuan, X., Zhu, J., Xiang, L., Li, Q., Deng, K., Li, X., & Liu, H. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001613 · Cited by 20
Chen, J., Lin, S., Zeng, G., Wang, W., Lin, Z., Xu, C., He, Y., Shi, J., Zhou, X., Niu, C., et al. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0491 · Cited by 20
“Second, several studies conducted in Western countries have shown that with the increase in the survival rate of premature infants, the incidence of neonatal CH increases year on year (14-15).”
BackgroundEpidemiology of Congenital Hypothyroidism
Olivieri, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_6 · Cited by 19
Self-citationNewborn screening for primary congenital hypothyroidism: past, present and future
L., F. G., Lain, S. J., & Olivieri, A. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0358 · Cited by 21
Self-citationDUOX2 variants are a frequent cause of congenital primary hypothyroidism in Thai patients
Sorapipatcharoen, K., Tim‐Aroon, T., Mahachoklertwattana, P., Chantratita, W., Iemwimangsa, N., Sensorn, I., Panthan, B., Jiaranai, P., Noojarern, S., Khlairit, P., et al. (2020) · Endocrine Connections · doi:10.1530/ec-20-0411 · Cited by 18
Molinari, S., FOSSATI, C., Nicolosi, M. L., Marco, S. D., Faraguna, M. C., Limido, F., Ocello, L., Pellegrinelli, C., Lattuada, M., Gazzarri, A., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1348397 · Cited by 24
A 7-year study on the prevalence of congenital hypothyroidism in northern Iran
Beheshti, Z., Rezaei, R., Alipour, A., Kosaryan, M., & Saatsaz, S. (2018) · Electronic physician · doi:10.19082/6689 · Cited by 17
“The reported prevalence of permanent CH is 1 per 2,320 births in Italy (40) and 1 per 2,367 births in Argentina (8).”
BackgroundBarry, Y., MANDEREAU, L., Bonaldi, C., Cheillan, D., Coutant, R., Léger, J., & Regnault, N. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab854 · Cited by 17
Heterogeneous phenotype in children affected by non-autoimmune hypothyroidism: an update
Vigone, M. C., Frenna, M. D., & Weber, G. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0288-5 · Cited by 16
“Moreover, in this period about 50 % of the increased incidence of both confirmed and permanent CH alone was attributable to preterm babies [16].”
BackgroundNascimento, M. L., Nascimento, A. L., Dornbusch, P., Ohira, M., Simoni, G., Cechinel, E., Linhares, R. M. M., Lee, J. V. D. S., & da Silva, P. C. A. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000299 · Cited by 14
“Cutoff levels between 5 and 10 mIU/L have been adopted by some programs, including those in the United Kingdom (10), Slovenia, Norway (18), Italy (19), and Iran (20), with the aim of decreasing false-negative rates, but have increased the number of false-positive results and recalls (4,8,21).”
A global perspective on newborn congenital hypothyroidism screening
Kopel, J. J. (2019) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2019.1668715 · Cited by 14
“Despite advances in genetic analysis, the etiology underlying thyroid dysgenesis remains elusive.1,2 However, several mutations in genes encoding thyroid peroxidase, thyroglobulin, and the sodiumiodide symporter are associated with CH.1,2 As shown in Table 1, there are five primary types of congenital hypothyroidism:…”
BackgroundResultInfluentialEvolution of congenital hypothyroidism in a cohort of preterm born children
Scavone, M., Giancotti, L., Anastasio, E., Pensabene, L., Sestito, S., & Concolino, D. (2020) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2020.07.014 · Cited by 18
Newborn screening for congenital hypothyroidism in Henan province, China
Zhao, D., Shen, Y., Gong, J., Meng, Y., Su, L., & Zhang, X. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.030 · Cited by 14
“The incidence of CH is 1 in 3500 live births and occurs in diverse populations in different geographic areas [4,14].”
BackgroundJiang, X., Huang, Y.-L., Feng, Y., Tang, F., Jia, X., Chen, Q., Tang, C., Liu, S., Li, B., Zheng, R., et al. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.018 · Cited by 16
Endocrine Diseases and Disorders of Thyroid Function in Newborns
Ghirri, P., Balsamo, A., Ciantelli, M., Cavarzere, P., Cicognani, A., Boldrini, A., & Cassio, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-29489-6_259 · Cited by 13
Pediatric Quality of Life in Congenital Hypothyroidism: an Indonesian Study
Rochmah, N., Faizi, M., Dewanti, C. N., & Suryawan, A. (2020) · International Journal of Thyroidology · doi:10.11106/ijt.2020.13.2.150 · Cited by 13
The Consensus on the Diagnosis and Management of Congenital Hypothyroidism in Term Neonates
Hashemipour, M., Rabbani, A., Rad, A. H., & Dalili, S. (2023) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_535_21 · Cited by 12
Scavone, M., Carboni, E., Stefanelli, E., Romano, G., Vero, A., Giancotti, L., MINIERO, R., & Talarico, V. (2018) · Indian Pediatrics · doi:10.1007/s13312-018-1442-x · Cited by 12
Lain, S. J., Wiley, V. C., Jack, M., Martin, A. J., Wilcken, B. M., & Nassar, N. (2020) · European Journal of Pediatrics · doi:10.1007/s00431-020-03828-9 · Cited by 13
“However, lowering NBS TSH cut-offs has implications for children and families as there is also an increase in the number of healthy infants recalled for further testing [10, 11].”
BackgroundAl-Qahtani, M. H. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1838480 · Cited by 15
“If the state of congenital hypothyroidism lasts for 3–6months it is called transient congenital hypothyroidism, another clinical definition of TCH is resolution of the hypothyroidism by age of 3 years [40].”
BackgroundChristensen‐Adad, F. C., Mendes-dos-Santos, C. T., Goto, M. M. F., SEWAYBRICKER, L. E., D’Souza-Li, L. F. R., Guerra‐Júnior, G., Morcillo, A. M., & de Lemos‐Marini, S. H. V. (2017) · Jornal de Pediatria · doi:10.1016/j.jped.2017.05.003 · Cited by 12
Ng, S. M., Turner, M. A., & Avula, S. (2017) · European Thyroid Journal · doi:10.1159/000481857 · Cited by 11
Butler, A. M., Charoensiriwatana, W., Krasao, P., Pankanjanato, R., Thong-Ngao, P., Polson, R. C., Snow, G. L., & Ehrenkranz, J. R. L. (2017) · Thyroid · doi:10.1089/thy.2016.0452 · Cited by 14
Donbaloğlu, Z., Erdeve, Ş. S., Çetinkaya, S. Ç., & Aycan, Z. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2018.0255 · Cited by 11
“63 (4-51); 10 (4%) of patients were diagnosed at follow up and the mean age of diagnosis was 43.”
BackgroundResultInfluentialMehran, L., Azizi, F., Mousapour, P., Cheraghi, L., Yarahmadi, S., Amirshekari, G., & Khalili, D. (2021) · Endocrine · doi:10.1007/s12020-021-02641-0 · Cited by 12
Donbaloğlu, Z., Çetinkaya, S. Ç., Aycan, Z., Küçükali, G. K., Şakar, M., & Erdeve, Ş. S. (2022) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.16025 · Cited by 12
The effect of thyroid functions on osteopenia of prematurity in preterm infants
Çakır, U., & Tayman, C. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0429 · Cited by 10
Braga, N. T. P., Antunes, J. M. V., Colosimo, E. A., Dias, V. M. A., Januário, J. N., & Silva, I. N. (2024) · International Journal of Neonatal Screening · doi:10.3390/ijns10030052 · Cited by 10
“The unequivocal benefits of treating children preemptively and reports of undiagnosed CH with current cut-offs of b-TSH have led many newborn screening programs to reduce the thresholds, resulting in a higher incidence of the disease [2,11–13].”
BackgroundInfluentialVincenzi, G., Petralia, I. T., Abbate, M. T. A., & Vigone, M. C. (2025) · European Thyroid Journal · doi:10.1530/etj-25-0019 · Cited by 10
“In summary, CH due to defects in thyroid embryogenesis accounted for approximately 58% of cases, while the remaining 42% could be related to defects in thyroid hormone synthesis (10).”
Doustmohamadian, S., Mehrizi, S., Rahbar, M. N., & Mirmohammadkhani, M. (2020) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_254_19 · Cited by 8
“in Italy in 2015, the incidence of CH had increased from a ratio of 1 to 3,000 to a ratio of 1 to 1,940 live births during the period 1987–1998 (period 1) and the period 1999–2008 (period 2).[19] In an investigation carried out by Deng et al.”
BackgroundChen, S., Yang, B., Li, J.-Y., Xu, P., & Wang, F. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0733 · Cited by 8
Yan, X., Wang, L., Chen, X., & Wang, A. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s400804 · Cited by 8
“screening items, the sensitivity of thyrotropin (TSH) detection, and the survival rate of premature infants, the incidence of CH has also increased worldwide.(3) The combination of genetic and environmental factors leads to neonatal CH.”
BackgroundGunnerbeck, A., Lundholm, C., von Döbeln, U., Zetterström, R. H., Almqvist, C., & Nordenström, A. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad064 · Cited by 9
GENETIC DEFECTS IN THYROID HORMONE SUPPLY
Nettore, I. C., Fenzi, G., & Macchia, P. E. (2014) · Cited by 9
Brusa, J., Maggio, M. C., Giustino, V., Thomas, E., Zangla, D., Iovane, A., Palma, A., Corsello, G., Messina, G., & Bellafiore, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17134830 · Cited by 10
van Trotsenburg, A. S. P., Stoupa, A., Léger, J., Rohrer, T. R., Peters, C. J., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.3.8 · Cited by 9
DNA Methylation of the EphA5 Promoter Is Associated with Rat Congenital Hypothyroidism
Wu, Y., Song, H., Sun, B., Xu, M., & Shi, J. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0603-9 · Cited by 8
“Accumulating evidence suggests that multiple factors influence the incidence of CH, although the underlying molecular mechanisms are largely unknown (Olivieri et al. 2015).”
BackgroundImpact of Lower Screening TSH Cutoff Level on the Increasing Prevalence of Congenital Hypothyroidism
Anastasovska, V., & Kočova, M. (2017) · International Journal of Neonatal Screening · doi:10.3390/ijns3020007 · Cited by 7
“A similar finding was reported from Italy, for a period of 20 years [6].”
BackgroundResultFirst Experiences with Newborn Screening for Congenital Hypothyroidism in Ulaanbaatar, Mongolia
Tsevgee, A., Batjargal, K., Munkhchuluun, T., Khurelbaatar, N., Nansal, G., Oyun-Erdene, B., Sumberzul, N., Zagd, G., & Ganbaatar, E. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7020029 · Cited by 7
“The overall prevalence of primary CH in our present study was similar to the estimates of recent studies conducted in Ireland (1:2200) [17], China (1:2278) [12], the United States of America (1:2350) [18], Saudi Arabia (1:2470) [19], and Taiwan (1:1992) [3], However, similar or even higher results were found in Italy…”
ResultClinical Insight into Congenital Hypothyroidism Among Children
Korkmaz, H. A. (2025) · Children · doi:10.3390/children12010055 · Cited by 8
Shaikh, A. M. A., Alsofyani, A., Shirah, B. H., Noaim, K. I. A., Ahmed, M. E., Babiker, A. M. I., & Alwan, I. A. A. (2021) · PubMed Central · Cited by 7
Spatial Distribution of Congenital Hypothyroidism
Mahaki, B., Mehrnejat, N., Zabihi, M., Dalvi, M., & Kazemitabaee, M. (2021) · Archives of Iranian Medicine · doi:10.34172/aim.2021.90 · Cited by 6
Congenital hypothyroidism after newborn screening program reorganization in the Apulia region
Simonetti, S., D’Amato, G., Esposito, B., Chiarito, M., Dentico, D., Lorè, T., Cardinali, R., Russo, S., Laforgia, N., & Faienza, M. F. (2022) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-022-01328-0 · Cited by 6
“The adoption of lower thyroid-stimulating hormone (TSH) cutoff levels [2, 3] together with the increased survival rate of preterm and low birth weight (LBW) infants [4, 5], and the introduction of re-screening for special categories of neonates at risk of delayed TSH rise [6, 7] resulted in an increased detection of m…”
BackgroundOral and systemic manifestations of congenital hypothyroidism in children. A case report.
Ayala, C. D. L. L., Lemus-Rojero, O., & Frías, M. (2015) · Journal Of Oral Research · doi:10.17126/joralres.2015.063 · Cited by 6
Etiology of Congenital Hypothyroidism
Bona, G., Bellone, S., Prodam, F., & Monzani, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_3 · Cited by 6
Congenital hypothyroidism in Northern Ireland: 40 years' experience of national screening programme
Darrat, M., Kayes, L., Woodside, J. V., Mullan, K., & Abid, N. (2023) · Clinical Endocrinology · doi:10.1111/cen.14940 · Cited by 5
“The growing population of pre‐term new‐borns was similar to previous reports.(27,28) There were 77 (16%) in our cohort diagnosed with CHT who were born preterm.”
ResultOrtolano, R., Cantarelli, E., Baronio, F., Assirelli, V., Candela, E., Mastrangelo, C., Vissani, S., Alqaisi, R. S., Lanari, M., & Cassio, A. (2024) · Children · doi:10.3390/children11091136 · Cited by 6
“In recent years, there has been an increasing trend in the incidence of CH, mostly attributed to the use of lower Thyroid-Stimulating Hormone (TSH) cut-off values in newborn screening programs [2,3].”
BackgroundEpidemiological profile of congenital hypothyroidism at a southern Brazilian state
Rizzotto, M. I. B., Kopacek, C., de Souza, V., Ribeiro, S. C., Kreisner, E., Vargas, P. R., Mastella, L. S., Madi, J. M., de Castro, S. M., & Garcia, R. M. R. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000606 · Cited by 4
Incidence and Risk Factor of Permanent Hypothyroidism in Preterm Infants
Chung, M. L. (2017) · Journal of Neonatal Biology · doi:10.4172/2167-0897.1000254 · Cited by 4
Azim, M. A. U., Islam, M. A., Biswasarma, S. C., Uddin, M. J., Jabin, Z., Begum, F. K., Begum, S. M., Alam, F., Hasan, M., Nahar, N., et al. (2022) · Bangladesh Journal of Nuclear Medicine · doi:10.3329/bjnm.v25i1.59636 · Cited by 4
Wu, S.-Y., Zhao, H., Xi, B.-X., Chen, D.-B., & Fucito, M. E. (2022) · Endocrinology and Disorders · doi:10.31579/2640-1045/122 · Cited by 5
“Similar increases (Table 1) were also observed in Australia [22], Italy [23], and Ireland [24].”
ResultSubclinical Hypothyroidism in Infancy: To Treat or Not to Treat, That Is the Question
Wassner, A. J., & Brown, R. S. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.12.001 · Cited by 4
Anastasovska, V., Pesevska, M., Zdraveska, N., Zafirova, B., Meceska-Jovcevska, J., & Kočova, M. (2023) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2022.594 · Cited by 3
Is It Time to Expand Newborn Screening for Congenital Hypothyroidism to Other Rare Thyroid Diseases?
Olivieri, A., Vigone, M. C., Salerno, M., & Persani, L. (2025) · International Journal of Neonatal Screening · doi:10.3390/ijns11030065 · Cited by 4
“…cutoffs along with other factors, such as increased survival rate of preterm babies and twin births, changes in screening population demographics, and a progressive adoption of re-screening strategy in infants at risk of delayed TSH rise [11–17], have led to an increased incidence of primary CH.”
Self-citationEndocrine Diseases and Disorders of Thyroid Function in Newborns
Ghirri, P., Balsamo, A., Ciantelli, M., Cavarzere, P., Cassio, A., Cicognani, A., & Boldrini, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-18159-2_259-1 · Cited by 3
FREQUENCY OF CONGENITAL HYPOTHYROIDISM IN HORMOZGAN PROVINCE, IRAN
Nazemi, A., Hamedi, Y., Rashidi, A., Eslami, M., & Gholami, A. (2018) · Acta healthmedica · doi:10.19082/ah253 · Cited by 3
“Also, in a study performed in Italy, the average age for beginning treatment was 23 days and 19 days in the first and second period, respectively (16).”
Peters, C. J., & Schoenmakers, N. A. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch8 · Cited by 3
Findley, T. O., Shah, A. N., Bell, C., & Khan, A. M. (2019) · Journal of Perinatology · doi:10.1038/s41372-019-0400-3 · Cited by 3
Fúnez, A., Lara, M. E., Chévez, A. C., Castellón, E. A., Perán, S., del Toro, M. J. P., Montoya, E., & varro, J. C. M. (2019) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1590/2326-4594-jiems-2019-0003 · Cited by 3
Oprea, O. R., Barbu, Ș., Kodori, D. R., & Dobreanu, M. (2021) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2021.22 · Cited by 3
Chamot, S., Petit, P., Al‐Salameh, A., Bonneterre, V., Cancé, C., Decocq, G., & Desailloud, R. (2024) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2024.100560 · Cited by 5
Vincenzi, G., Tarantola, G., Mora, S., Abbate, M. T. A., Santagiuliana, C., Petralia, I. T., Giacco, L. D., Zanelli, S., Barera, G., & Vigone, M. C. (2025) · Endocrine · doi:10.1007/s12020-025-04230-x · Cited by 2
“…between January 2011 and June 2020, while patients in group B started L-T4 between May 2020 and July 2022, this might re fl ect the increased attention in diagnosis and the improvement of the neonatal screening program, which allowed us to detect even milder CH cases than in the past [19 – 21].”
Swan, J., Zhurenko, D., Huttunen, K. M., & Rysä, J. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04203-z · Cited by 2
“…that the upward trend of congenital hypothyroidism incidence may be due to changes in population demographics, the increasing survival rate of preterm infants, and the lowering of thyroid-stimulating hormone (TSH) cutoff values (Harris and Pass 2007; Albert et al. 2012; Olivieri et al. 2015).”
Su, Y., Lei, X., Muhetaer, A., He, J., & Li, L. (2025) · International Journal of Neonatal Screening · doi:10.3390/ijns11040098 · Cited by 2
“Previous studies indicated that while 85% of CH cases have historically been attributed to TD [18], an increased proportion of CH cases caused by DH has been reported recently [19,20].”
Pignata, L., Bagattini, B., Cosmo, C. D., Agretti, P., Marco, G. D., Ferrarini, E., Montanelli, L., & Tonacchera, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae471 · Cited by 2
Hung, P., Lui, C., Lee, C., Chien, Y., Chen, F.-S., Chen, C., Yu, H., Chung, M., & Huang, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5440 · Cited by 2
“The cut‑off value of TSH is defined as 9 µU/ml, which has been reported to be sensitive for detecting newborns with congenital hypothyroidism (21).”
Bernal, S. Y., & Meager, M. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_25 · Cited by 2
Çakır, U., Tayman, C., Bekmez, B. Ö., Büyüktiryaki, M., & Yarcı, E. (2020) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2019.49469 · Cited by 2
Shin, Y. (2018) · Journal of Korean Medical Association · doi:10.5124/jkma.2018.61.10.607 · Cited by 2
Tan, M., Jiang, X., Mei, H.-F., Feng, Y., Xie, T., Tang, C., Chen, Q.-Y., Zeng, C., & Huang, Y. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0107 · Cited by 2
Congenital Hypothyroidism Screening Results in the Turkish Province of Adiyaman in 2015-2020
Bolu, F., & Bolu, S. (2024) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2024.201 · Cited by 1
Metadata
- Authors
- Olivieri, A., Fazzini, C., Medda, E., & The Italian Study Group for Congenital Hypothyroidism
- Affiliations
- Istituto Superiore di Sanità (IT)
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 83
- Issue
- 2
- Pages
- 86-93
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2014203385
- Cited by
- 132
- References
- 35
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 10 · 2023: 9 · 2022: 12 · 2021: 13 · 2020: 18 · 2019: 10 · 2018: 16 · 2017: 11 · 2016: 4 · 2015: 10
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- congenital hypothyroidism, incidence trends, newborn screening, transient hypothyroidism, preterm infants, Italy
- MeSH terms
- Congenital Hypothyroidism, Female, Humans, Infant, Newborn, Infant, Premature, Italy, Male, Mass Screening, Retrospective Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.